El Vínculo El Vínculo.
Closed European Union SuppliesFramework agreement

MEDICAMENTE ANTINEOPLAZICE 1

Buyer: SPITALUL CLINIC C.F. CLUJ

Published
19 May 2025
Submission deadline
23 June 2025, 15:00
Procedure
Open procedure
Documents
1
Notice number
00320763-2025
Reference
b215b23a-1ae0-4030-9214-e483a8ad84fb
Official source
Official source

CPV codes

Description

Medicamente antineoplazice 1. A se vedea Caietul de sarcini.Autoritatea contractanta va raspunde in mod clar si complet tuturor solicitarilor de clarificare/informatiilor suplimentare in a 12-a zi inainte de termenul limita stabilit pentru depunerea ofertelor, Nr zile pana la care se pot solicita clarificari inainte de data de depunere a ofertelor este 20

Lots (44)

LotDescriptionCPV codeAmount
1 Acidum zolendronicum - fl.4 mg - 100 ml
RO113
33652100 Agentes antineoplásicos
2 Avelumabum - 1 flacon x 10 ml conc. pt. sol. perf. 200 mg
RO113
33652100 Agentes antineoplásicos
3 Afliberceptum - flc.100 mg
RO113
33652100 Agentes antineoplásicos
4 Atezolizumabum - fl 1200 mg
RO113
33652100 Agentes antineoplásicos
5 Bevacizumabum -inovativ - fl.100 mg
RO113
33652100 Agentes antineoplásicos
6 Bevacizumabum -inovativ - fl.400 mg
RO113
33652100 Agentes antineoplásicos
7 Bevacizumabum -biosimilar - fl.100 mg
RO113
33652100 Agentes antineoplásicos
8 Bevacizumabum -biosimilar - fl.400 mg
RO113
33652100 Agentes antineoplásicos
9 Cabazitaxelum - flc.60mg/1,5 ml
RO113
33652100 Agentes antineoplásicos
10 Carboplatinum - fl. 450 mg
RO113
33652100 Agentes antineoplásicos
11 Calcii folinas - flc.10mg/ml;fl.10 ml
RO113
33652100 Agentes antineoplásicos
12 Cemiplimabum - 50mg/ml x 7 ml conc. pt. sol. perf. (350 mg cemiplimab)
RO113
33652100 Agentes antineoplásicos
13 Cetuximabum - flac. 20 ml - conc 5mg/ml
RO113
33652100 Agentes antineoplásicos
14 Cisplatinum - fl. 50 mg
RO113
33652100 Agentes antineoplásicos
15 Cyclophosphamidum - fl.200 mg
RO113
33652100 Agentes antineoplásicos
16 Cyclophosphamidum - fl.1000 mg
RO113
33652100 Agentes antineoplásicos
17 Docetaxelum - conc.pt.sol .perf.fl 140 mg
RO113
33652100 Agentes antineoplásicos
18 Docetaxelum - conc.pt.sol.perf., fl. 160 mg
RO113
33652100 Agentes antineoplásicos
19 Docetaxelum - conc.pt.sol.perf., fl. 80 mg
RO113
33652100 Agentes antineoplásicos
20 Durvalumab - 1 flac.2,4 ml conc.(120mg)
RO113
33652100 Agentes antineoplásicos
21 Epirubicinum - sol.inj/perf, fl. 100 mg
RO113
33652100 Agentes antineoplásicos
22 Etoposidum -fl.100 mg
RO113
33652100 Agentes antineoplásicos
23 Filgrastim - fl.30 mui
RO113
33652100 Agentes antineoplásicos
24 Fluorouracilum - 50mg/ml,flc. 20 ml
RO113
33652100 Agentes antineoplásicos
25 Gemcitabinum - fl. 1 g
RO113
33652100 Agentes antineoplásicos
26 Gemcitabinum - fl. 2 g
RO113
33652100 Agentes antineoplásicos
27 Iplimumabum - flc.50 mg
RO113
33652100 Agentes antineoplásicos
28 Irinotecanum - fl. 100 mg
RO113
33652100 Agentes antineoplásicos
29 Irinotecanum - fl.300 mg
RO113
33652100 Agentes antineoplásicos
30 Irinotecanum Liposomalum - 4,3mg/ml x10ml
RO113
33652100 Agentes antineoplásicos

Award criteria

Official publications

Other tenders from SPITALUL CLINIC C.F. CLUJ

Frequently asked questions

What is the deadline to bid for this tender?
The submission deadline is 23 June 2025, 15:00. Check the official source, as dates can be modified.
Who is the buyer of this tender?
The contracting authority is SPITALUL CLINIC C.F. CLUJ (European Union).
How can I bid for public tenders in European Union?
Bids are submitted through the official procurement portal of European Union. El Vínculo helps you find tenders and analyse their documents; submission always happens at the official source.
Get alerts for tenders like this
Create a free account and receive new tenders from European Union matching your business, every day.

Start for free

Data collected from official public procurement sources. Amounts as published by the buyer.